Suchergebnisse - "Heidenreich, Axel"

PubPharm (759)

1

Cystic Pelvic Masses in Men : A Presentation of Uncommon Cases and a Literature Review

enthalten in: Clinical genitourinary cancer | 2024

von Rieger, C. | Pfister, D. | Kastner, L. | +4

2

HIVEC as an alternative option in non-muscle-invasive bladder cancer : Experiences from a high-volume center

enthalten in: Urologic oncology | 2024

von Kastner, L. | Rieger, C. | Pfister, D. | +3

3

Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer : Results from the IGCCCG Update Consortium

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Bührer, E. | D'Haese, D. | Daugaard, G. | +32

4

Assessing the risk to develop a growing teratoma syndrome based on molecular and epigenetic subtyping as well as novel secreted biomarkers

enthalten in: Cancer letters | 2024

von Pongratanakul, P. | Bremmer, F. | Pauls, S. | +14

5

Palliative surgery for metastatic prostate cancer

enthalten in: Urologie (Heidelberg, Germany) | 2024

von Heidenreich, A. | Bach, C. | Pfister, D.

6

Palliative urologic surgery for metastatic prostate cancer : what needs to be considered in the future?

enthalten in: Aktuelle Urologie | 2024

von Heidenreich, A. | Bach, C. | Pfister, D.

7

Significant Survival Differences for Grade Group 4 and Grade Group 5 Prostate Cancer : Detailed Reporting of Pathohistology and Modern Diagnostic Algorithms Are Needed To Tailor Treatment

enthalten in: European urology oncology | 2024

von Heidenreich, A.

8

Cost-effectiveness analysis of different treatment modalities in BCG-unresponsive NMIBC

enthalten in: BJU international | 2024

von Rieger, C. | Schlüchtermann, J. | Storz, E. | +3

9

enthalten in: Aktuelle Urologie | 2024

von Heidenreich, A.

10

Reply to Fumihiko Urabe, Takashi Yoshioka, and Takahiro Kimura's Letter to the Editor re : Felix Seelemeyer, David Pfister, Robert Pappesch, Sabine Merkelbach-Bruse, Pia Paffenholz and Axel Heidenreich. Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.10.021

enthalten in: European urology oncology | 2024

von Seelemeyer, F. | Pfister, D. | Pappesch, R. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[76]